USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like Ex-servicemen will require Aadhaar to avail pension benefits: Government April 1, 2017 IBC cases: Govt in talks with RBI to relax provisioning norms October 12, 2017 The Airbus A220 Takes Aim at the 737 MAX November 4, 2019